| Name | Title | Contact Details |
|---|
Fortimedix Surgical is a fast growing medical device company with the ambition to inspire a new wave of technological advancement in the field of minimally invasive surgery. The company is headquartered in Nuth, The Netherlands, and has a US subsidiary in San Diego, CA. With a strong history as a global market leader in contract stent manufacturing, Fortimedix has been a trusted partner in the medical device industry for over 15 years. Building on our established position as a stent industry leader with state-of-the-art manufacturing capabilities, we have in-house control over the manufacturing of key components of our products, including the symphonX™ Surgical Platform. Thanks to our network within the medical device industry, we are able to work with various professional service providers for the supply of other platform components and services. This allows us to outsource cost by leveraging their expertise and infrastructure.
Medical Science Distributors L is a Tempe, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
KPI Ultrasound LLC is a Riverside, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
LODOX SYSTEMS NA is a South Lyon, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Invendo Medical aims to become a globally leading developer and distributor of disposable, highly flexible and easy-to-use endoscopy products in the field of gastroenterology. Innovation activity in gastroenterological endoscopy has in the past decades nearly exclusively focused on the improvement of optical capabilities. However, invendo medical´s goal is to improve patient compliance and thereby increase the number of procedures performed. In order to achieve its goal the company first focussed on an application in the diagnosis and treatment of colorectal cancers (CRC). CRC is the second leading cause of cancer death with an estimated annual worldwide death toll of 510,000 people. More than 1 million new cases are diagnosed every year. However 90-100% of colorectal cancers can be avoided if diagnosed early on